Tim Evans
Stock Analyst at Wells Fargo
(2.36)
# 2,572
Out of 5,154 analysts
23
Total ratings
72.73%
Success rate
4.35%
Average return
Main Sectors:
Stocks Rated by Tim Evans
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $269.85 | +3.76% | 2 | Feb 28, 2018 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $290 → $280 | $278.21 | +0.64% | 2 | Feb 28, 2018 | |
| MEDP Medpace Holdings | Maintains: Market Perform | $38 → $35 | $470.59 | -92.56% | 3 | Feb 28, 2018 | |
| ILMN Illumina | Upgrades: Outperform | n/a | $124.62 | - | 2 | Jan 2, 2018 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $105 → $112 | $245.86 | -54.45% | 4 | Oct 27, 2017 | |
| DGX Quest Diagnostics | Maintains: Market Perform | $88 → $86 | $199.21 | -56.83% | 2 | Oct 20, 2017 | |
| LH Labcorp Holdings | Reinstates: Outperform | $175 | $269.67 | -35.11% | 1 | Oct 12, 2017 | |
| TECH Bio-Techne | Initiates: Market Perform | n/a | $53.89 | - | 1 | Jul 13, 2017 | |
| DHR Danaher | Initiates: Market Perform | $90 | $195.50 | -53.96% | 1 | Jul 13, 2017 | |
| MTD Mettler-Toledo International | Upgrades: Outperform | n/a | $1,209.65 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $36.68 | - | 2 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $115.07 | - | 1 | Jul 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.82 | - | 1 | May 3, 2017 |
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $269.85
Upside: +3.76%
Bio-Rad Laboratories
Feb 28, 2018
Maintains: Outperform
Price Target: $290 → $280
Current: $278.21
Upside: +0.64%
Medpace Holdings
Feb 28, 2018
Maintains: Market Perform
Price Target: $38 → $35
Current: $470.59
Upside: -92.56%
Illumina
Jan 2, 2018
Upgrades: Outperform
Price Target: n/a
Current: $124.62
Upside: -
West Pharmaceutical Services
Oct 27, 2017
Maintains: Outperform
Price Target: $105 → $112
Current: $245.86
Upside: -54.45%
Quest Diagnostics
Oct 20, 2017
Maintains: Market Perform
Price Target: $88 → $86
Current: $199.21
Upside: -56.83%
Labcorp Holdings
Oct 12, 2017
Reinstates: Outperform
Price Target: $175
Current: $269.67
Upside: -35.11%
Bio-Techne
Jul 13, 2017
Initiates: Market Perform
Price Target: n/a
Current: $53.89
Upside: -
Danaher
Jul 13, 2017
Initiates: Market Perform
Price Target: $90
Current: $195.50
Upside: -53.96%
Mettler-Toledo International
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $1,209.65
Upside: -
Jul 13, 2017
Downgrades: Underperform
Price Target: n/a
Current: $36.68
Upside: -
Jul 13, 2017
Upgrades: Outperform
Price Target: n/a
Current: $115.07
Upside: -
May 3, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $0.82
Upside: -